Reduced expression of angiotensin II and angiotensin receptor type 1 and type 2 in resistance arteries from nasal lesions in granulomatosis with polyangiitis (Wegener's granulomatosis)

Scandinavian Journal of Rheumatology

Volumn 40, Issue 6, 2011, Pages 448-452

  Dimitrijevic, I ^a   Rissler, P ^a   Luts, L ^a   Edvinsson, L ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; EOSIN; FORMALDEHYDE; HEMATOXYLIN; PARAFFIN;

ARTERY RESISTANCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; MUCOSA; NASAL BIOPSY; NOSE DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SMOOTH MUSCLE FIBER; STAINING; WEGENER GRANULOMATOSIS;

ANGIOTENSIN II; CASE-CONTROL STUDIES; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; MYOCYTES, SMOOTH MUSCLE; NASAL MUCOSA; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; WEGENER GRANULOMATOSIS;

EID: 83455219943     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2011.593545     Document Type: Article

References (13)

1. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488-98.
2. Nienhuis HL, de Leeuw K, Smit AJ, Bijzet J, Stegeman CA, Kallenberg CG et al. Enhanced endothelium-dependent microvascular responses in patients with Wegener's granulomatosis. J Rheumatol 2007;34:1875-81. (Pubitemid 350067649)
3. Petrie MC, Padmanabhan N, McDonald JE, Hillier C, Connell JM, McMurray JJ. Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease. J Am Coll Cardiol 2001;37:1056-61. (Pubitemid 32217606)
4. Li M, Liu K, Michalicek J, Angus JA, Hunt JE, Dell'Italia LJ, et al. et al. Involvement of chymase-mediated angiotensin II generation in blood pressure regulation. J Clin Invest 2004;114:112-20. (Pubitemid 39071650)
5. Kumar R, Singh VP, Baker KM. The intracellular renin-angiotensin system: implications in cardiovascular remodeling. Curr Opin Nephrol Hypertens 2008;17:168-73. (Pubitemid 351253042)
6. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007;292:C82-97. (Pubitemid 46127306)
7. Bloch DA, Michel BA, Hunder GG, McShane DJ, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Patients and methods. Arthritis Rheum 1990;33:1068-73. (Pubitemid 20273290)
8. Dimitrijevic I, Malmsjo M, Andersson C, Rissler P, Edvinsson L. Increased angiotensin II type 1 receptor expression in temporal arteries from patients with giant cell arteritis. Ophthalmology 2009;116:990-6.
9. Unger T, Chung O, Csikos T, Culman J, Gallinat S, Gohlke P, et al. et al. Angiotensin receptors. J Hypertens 1996;14(Suppl 5):S95-103.
10. Wassmann S, Nickenig G. Pathophysiological regulation of the AT1-receptor and implications for vascular disease. J Hypertens Suppl 2006;24:S15-21. (Pubitemid 44336819)
11. Sasamura H, Nakazato Y, Hayashida T, Kitamura Y, Hayashi M, Saruta T. Regulation of vascular type 1 angiotensin receptors by cytokines. Hypertension 1997;30:35-41. (Pubitemid 27306344)
12. Wang CH, Li SH, Weisel RD, Fedak PW, Dumont AS, Szmitko P, et al. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation 2003;107: 1783-90. (Pubitemid 36418360)
13. Huugen D, Tervaert JW, Heeringa P. TNF-alpha bioactivityinhibiting therapy in ANCA-associated vasculitis: clinical and experimental considerations. Clin J AmSoc Nephrol 2006;1:1100-7.